These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19937354)

  • 1. Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study.
    Russo GT; Di Benedetto A; Magazzù D; Giandalia A; Giorda CB; Ientile R; Previti M; Di Cesare E; Cucinotta D
    Acta Diabetol; 2011 Jun; 48(2):95-101. PubMed ID: 19937354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma total homocysteine levels and methylenetetrahydrofolate reductase gene polymorphism in patients with type 2 diabetes mellitus.
    Soares AL; Fernandes AP; Cardoso JE; Sousa MO; Lasmar MC; Novelli BA; Lages GF; Dusse LM; Vieira LM; Lwaleed BA; Carvalho MG
    Pathophysiol Haemost Thromb; 2008; 36(5):275-81. PubMed ID: 19996639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of total homocysteine plasma concentration in type 2 diabetes.
    Russo GT; Di Benedetto A; Giorda C; Alessi E; Crisafulli G; Ientile R; Di Cesare E; Jacques PF; Raimondo G; Cucinotta D
    Eur J Clin Invest; 2004 Mar; 34(3):197-204. PubMed ID: 15025678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
    Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between end-stage diabetic nephropathy and methylenetetrahydrofolate reductase genotype with macroangiopathy in type 2 diabetes mellitus.
    Hasegawa G; Obayashi H; Kamiuchi K; Nakai M; Kanatsuna T; Yamaguchi M; Tanaka T; Shigeta H; Fujii M; Yoshikawa T; Nakamura N
    Exp Clin Endocrinol Diabetes; 2003 May; 111(3):132-8. PubMed ID: 12784186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylenetetrahydrofolate reductase gene polymorphism, homocysteine and risk of macroangiopathy in Type 2 diabetes mellitus.
    Sun J; Xu Y; Zhu Y; Lu H
    J Endocrinol Invest; 2006 Oct; 29(9):814-20. PubMed ID: 17114913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinemia is a risk factor of recurrent coronary event in young patients irrespective to the MTHFR C677T polymorphism.
    Gonzalez-Porras JR; Martin-Herrero F; Garcia-Sanz R; Lopez ML; Balanzategui A; Mateos MV; Pavon P; Gonzalez M; Alberca I; San Miguel JF
    Thromb Res; 2007; 119(6):691-8. PubMed ID: 17005242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients.
    Mtiraoui N; Ezzidi I; Chaieb M; Marmouche H; Aouni Z; Chaieb A; Mahjoub T; Vaxillaire M; Almawi WY
    Diabetes Res Clin Pract; 2007 Jan; 75(1):99-106. PubMed ID: 16828193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes.
    Hermans MP; Gala JL; Buysschaert M
    Diabet Med; 2006 May; 23(5):529-36. PubMed ID: 16681562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients.
    Adinolfi LE; Ingrosso D; Cesaro G; Cimmino A; D'Antò M; Capasso R; Zappia V; Ruggiero G
    Hepatology; 2005 May; 41(5):995-1003. PubMed ID: 15834927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma total homocysteine levels in children with type 1 diabetes: relationship with vitamin status, methylene tetrahydrofolate reductase genotype, disease parameters and coronary risk factors.
    Dinleyici EC; Kirel B; Alatas O; Muslumanoglu H; Kilic Z; Dogruel N
    J Trop Pediatr; 2006 Aug; 52(4):260-6. PubMed ID: 16401615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild hyperhomocysteinemia and the common C677T polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes.
    Russo GT; Di Benedetto A; Alessi E; Ientile R; Antico A; Nicocia G; La Scala R; Di Cesare E; Raimondo G; Cucinotta D
    J Endocrinol Invest; 2006 Mar; 29(3):201-7. PubMed ID: 16682831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of the methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy.
    Eroglu Z; Erdogan M; Tetik A; Karadeniz M; Cetinalp S; Kosova B; Gunduz C; Ozgen AG; Yilmaz C
    Diabetes Metab Res Rev; 2007 Nov; 23(8):621-4. PubMed ID: 17354258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 677TT polymorphism of methylenetetrahydrofolate reductase in combination with low serum vitamin B12 is associated with coronary in-stent restenosis.
    Chung SL; Chiou KR; Charng MJ
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):349-55. PubMed ID: 16489563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
    de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
    J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on homocysteine levels and methylenetetrahydrofolate reductase gene variant (C677T) in a population of Buenos Aires City.
    Fridman O; Porcile R; Vanasco V; Junco MN; Gariglio L; Potenzoni MA; Bañes I; Morales A
    Clin Exp Hypertens; 2008 Oct; 30(7):574-84. PubMed ID: 18855261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild hyperhomocysteinemia and low folate concentrations as risk factors for cervical arterial dissection.
    Arauz A; Hoyos L; Cantú C; Jara A; Martínez L; García I; Fernández Mde L; Alonso E
    Cerebrovasc Dis; 2007; 24(2-3):210-4. PubMed ID: 17596690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence that hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T and A1289C polymorphisms are not risk factors for schizophrenia.
    Vilella E; Virgos C; Murphy M; Martorell L; Valero J; Simó JM; Joven J; Fernández-Ballart J; Labad A
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Sep; 29(7):1169-74. PubMed ID: 16076517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermolabile methylenetetrahydrofolate reductase enzyme genotype is frequent in type 2 diabetic patients with normal fasting homocysteine levels.
    Tutuncu NB; Erbas T; Alikasifoglu M; Tuncbilek E
    J Intern Med; 2005 May; 257(5):446-53. PubMed ID: 15836661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and changes in homocysteine concentrations in women with idiopathic recurrent pregnancy losses.
    Mtiraoui N; Zammiti W; Ghazouani L; Braham NJ; Saidi S; Finan RR; Almawi WY; Mahjoub T
    Reproduction; 2006 Feb; 131(2):395-401. PubMed ID: 16452733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.